Provided by Tiger Trade Technology Pte. Ltd.

SHANDONG XINHUA

5.815
+0.1101.93%
Volume:1.10M
Turnover:6.43M
Market Cap:4.05B
PE:11.84
High:5.890
Open:5.675
Low:5.660
Close:5.705
52wk High:7.418
52wk Low:5.029
Shares:697.00M
HK Float Shares:195.00M
Volume Ratio:0.82
T/O Rate:0.57%
Dividend:0.18
Dividend Rate:3.02%
EPS(LYR):0.491
ROE:4.10%
ROA:1.89%
PB:0.66
PE(LYR):11.84
PS:0.41

Loading ...

AH Premium Statistics Report | September 23

Stock News
·
Sep 23

Shandong Xinhua Pharmaceutical Flags Abnormal A-Share Trading Activity, Confirms No Revisions Needed to Prior Disclosures

Stock News
·
Sep 22

Xinhua Pharma Obtains Three Drug Certificates from Chinese Regulator

MT Newswires Live
·
Sep 18

Shandong Xinhua Secures Regulatory Approval for Levocarnitine Oral Solution

Stock News
·
Sep 18

Xinhua Pharmaceutical Obtains NMPA Approval for Magnesium-, Sodium- and Potassium-Based Bowel-Cleansing Solution

Bulletin Express
·
Sep 18

Xinhua Pharmaceutical Secures NMPA Registration for Levocarnitine Oral Solution

Bulletin Express
·
Sep 18

Shandong Xinhua's Subsidiary Secures Regulatory Approval for Donepezil Orally Disintegrating Tablets

Stock News
·
Sep 18

Shandong Xinhua Pharmaceutical - Magnesium Sulfate, Sodium Sulfate, Potassium Sulfate Concentrate Oral Solution Got Drug Registration Certificate

THOMSON REUTERS
·
Sep 18

Shandong Xinhua Pharmaceutical Co - National Medical Products Administration Approves Donepezil Hydrochloride Tablets

THOMSON REUTERS
·
Sep 18

Shandong Xinhua Pharmaceutical Co - Xincat Pharmaceutical Receives Drug Registration Certificate for Donepezil Hydrochloride Tablets

THOMSON REUTERS
·
Sep 18

Shandong Xinhua Pharma Posts Stable Share Capital in August 2026 Monthly Return

Bulletin Express
·
Sep 01

Xinhua Pharmaceutical Secures NMPA Drug Registration Certificate for Dapoxetine Hydrochloride Tablets

Bulletin Express
·
Aug 28

Shandong Xinhua Pharmaceutical (SEHK:719) Stock Can Margins Recover After Profit Halved

Simply Wall St.
·
Aug 26

China's Shandong Xinhua Profit Drops on Domestic, International Competition

Reuters
·
Aug 25

Shandong Xinhua Pharma Announces Plans for Derivative Hedging Activities

Stock News
·
Aug 25

Xinhua Pharmaceutical Gets Registration Certificate for Diabetes Mellitus Drug in China

MT Newswires Live
·
Aug 21

Shandong Xinhua Secures Regulatory Approval for Dapagliflozin Tablets

Stock News
·
Aug 21

Shandong Xinhua Pharmaceutical Schedules Board Meeting to Approve 1H26 Interim Results

Bulletin Express
·
Aug 11

Shandong Xinhua: No Share Capital Changes in July; Public-Float Compliance Affirmed

Bulletin Express
·
Aug 03

E Fund Management Boosts Stake in Shandong Xinhua Pharmaceutical by 198,000 Shares at Approximately HK$6.26 Each

Stock News
·
Jul 28